Table 1.
Characteristics of the subjects included in this study
| Category | Control | HTN | HTN+T2DM |
|---|---|---|---|
| Group (N) | 81 | 88 | 87 |
| Gender (female) % | 61.7 | 63.6 | 58.6 |
| Age (years) | 64.9±10.5a,b | 69.9±9.0 | 70±10.5 |
| Medication (%) | |||
| Dmeds | 0b | 0c | 83.9 |
| Antihypertensive | 0a,b | 68.2c | 87.4 |
| Statins | 13.6b | 21.6c | 75.9 |
| NSAID | 25.9a,b | 48.9 | 55.2 |
| Glucose (mmol/L) | 5.3±0.7b | 5.3±0.6c | 8.3±3.5 |
| BMI (kg/m2) | 25.7±4.1a,b | 28.1±5.0c | 30.3±6.1 |
| WC (cm) | |||
| Female | 88±10.1a,b | 94.8±18.5c | 99±14.3 |
| Male | 97.4±9.7b | 102.2±10.7c | 108.2±14.6 |
| Systolic BP (mmHg) | 119.7±11.2a,b | 138.5±18.5 | 137.5±18.4 |
| Diastolic BP (mmHg) | 73.6±6.4a,b | 78.9±7.6 | 77.4±9.6 |
| HbA1c (%) | 5.6±0.3b | 5.7±0.3c | 6.7±0.8 |
| TC (mmol/L) | 5.3±0.8b | 5.6±1c | 4.5±1.2 |
| Triglyceride (mmol/L) | 1.1±0.6b | 1.3±0.6c | 1.8±1.2 |
| HDL-C (mmol/L) | 1.7±0.4b | 1.6±0.5c | 1.4±0.6 |
| LDL-C (mmol/L) | 3.1±0.7b | 3.3±1c | 2.2±0.9 |
| TC/HDL-C ratio | 3.3±1a | 3.7±1.1 | 3.5±1.4 |
Notes:
a
Significant difference between control and HTN group (p<0.05);
b
significant difference between control and HTN+T2DM group (p<0.05);
c
significant difference between HTN and HTN+T2DM group (p<0.05).
Abbreviations: BP, blood pressure; Dmeds, diabetes medication; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; NSAID, non-steroidal anti-inflammatory drugs; T2DM, type 2 diabetes mellitus; TC, total cholesterol; WC, waist circumference.